Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Why Is Chronic Disease Focused Biora Therapeutics Stock Trading Higher Today?
Via Benzinga
Exposures Product Safety
Tickers BIOR
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM Encourages Outlook Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - OTLK
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers OTLK
Revolutionizing gastroparesis treatment: Evoke Pharma's CEO talks game-changing nasal spray
Via News Direct
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Revolutionizing gastroparesis treatment: Evoke Pharma's CEO talks game-changing nasal spray
Via TheNewswire.com
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Why Is This Rare Disease-Focused Soligenix Stock Trading Over 200% Today?
Via Benzinga
Exposures Product Safety
Tickers SNGX
ExoAtlet Unveils Groundbreaking ExoAtlet 2 and Industry-First Pediatric Exoskeleton
Via Press Release Distribution Service
Exposures Product Safety
InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Announces Participation in December MedInvest Oncology Investor Conference
Via Investor Brand Network
Exposures Product Safety
Tickers PCSA
Why Is Soligenix (SNGX) Stock Up 285% Today?
Via InvestorPlace
Exposures Product Safety
Tickers IMGN MINM QS SNGX
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) CEO Discussed ‘Breakthrough’ FDA Clearance in Proactive Interview
Via Investor Brand Network
Exposures Product Safety
Tickers VVOS
ROSEN, A LEADING AND RANKED FIRM, Encourages SCYNEXIS, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SCYX
Via NewMediaWire
Topics Lawsuit Product Recall
Exposures Financial Legal Product Safety
Tickers SCYX
Cannabis Mold Alert In Arizona, California Nears $5.5B Tax Milestone, Search For Marijuana Breathalyzer
Via Benzinga
Topics Cannabis Product Recall
Exposures Cannabis Legal Product Safety
Vivos Therapeutics hits major milestone with FDA clearance for treating severe sleep apnea
Via News Direct
Exposures Product Safety
Vivos Therapeutics hits major milestone with FDA clearance for treating severe sleep apnea
Via TheNewswire.com
Exposures Product Safety
Yoonpak: Pioneering Paper Cup Manufacturers in Sustainable Packaging
Via AB Newswire
Exposures Product Safety
InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Releases Shareholder Letter
Via Investor Brand Network
Exposures Product Safety
Tickers PCSA
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces First-Ever FDA Clearance for Treatment of Severe Obstructive Sleep Apnea Using Oral Device
Via Investor Brand Network
Exposures Product Safety
Tickers VVOS
InvestorNewsBreaks – Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Updates Special Access Program
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Tickers MYCOF
Why Is Sleep Disorder Device Provider Vivos Therapeutics Stock Trading Higher Today?
Via Benzinga
Exposures Product Safety
Tickers VVOS
Therma Bright Prepares FDA 513(g) Review Document for its AI-Driven Digital Cough Analyzer (DCA)
Via Newsfile
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Tickers AAPL TBRIF TSX-V:THRM
Eyes On Novartis, Gilead, Bristol Myers As FDA Weighs Risks Vs. Benefits Of Approved CAR T-Cell Therapies
Via Benzinga
Exposures Product Safety
Tickers BMY GILD JNJ NVS
Distinguished author and life coach Eric North shares guidance on making the holidays happier
Via IssueWire
Topics Product Recall
Exposures Legal Product Safety
New Partnership Between Generis And Risetime Provides Easy and Compliant Information Management for Cosmetics Industry
Via PRLog
Exposures Product Safety
Tickers PFE
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages SCYNEXIS, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SCYX
Via NewMediaWire
Topics Lawsuit Product Recall
Exposures Financial Legal Product Safety
Tickers SCYX
Imugene thrilled as VAXINIA granted FDA Fast Track designation
Via TheNewswire.com
Exposures Product Safety
Tickers ASX:IMU IUGNF
Imugene thrilled as VAXINIA granted FDA Fast Track designation
Via News Direct
Exposures Product Safety
Tickers ASX:IMU IUGNF
Li & Liao Optometry Acquires IPL: the Only FDA-Approved Device for Dry Eye
Via Press Advantage
Exposures Product Safety
SpringWorks Catapults 24% On A 'Watershed Moment' In Cancer Treatment
Via Investor's Business Daily
Exposures Product Safety
Tickers SWTX
FDA Rejects Aldeyra Therapeutics' Dry Eye Disease Candidate, Asks For Additional Study
Via Benzinga
Exposures Product Safety
Tickers ALDX
Unlocking Potential: Immunoassay Market Insights on Industry Size, Key Trends, Emerging Demands, and Prospects Extending to (2023-2028)
Via SBWire
Exposures Product Safety
Why SpringWorks Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Exposures Product Safety
Tickers ALYA ARGX ASST CWBR
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.